Cancer signaling pathway could illuminate new avenue to therapy

Researchers have better defined a pro-growth signaling pathway common to many cancers that, when blocked, kills cancer cells but leaves healthy cells comparatively unharmed. The study could establish new avenues of therapeutic treatments for many types of solid tumors.